A pilot study to investigate the feasibility and cardiac effects of pegylated liposomal doxorubicin (PL-DOX) as adjuvant therapy in medically fit elderly breast cancer patients

Critical Reviews in Oncology/Hematology

Volumn 67, Issue 2, 2008, Pages 133-138

  Wildiers, Hans ^a   Jurcut, Ruxandra ^a,c   Ganame, Javier ^a   Herbots, Lieven ^a   Neven, Patrick ^a   De Backer, Julie ^b   Denys, Hannelore ^b   Cocquyt, Veronique ^b   Rademakers, Frank ^a   Voigt, Jens Uwe ^a   Paridaens, Robert ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Breast cancer; Cardiac effects; Doppler myocardial imaging; Elderly; Pegylated liposomal doxorubicin

Indexed keywords

ANTHRACYCLINE DERIVATIVE; BRAIN NATRIURETIC PEPTIDE; CYCLOPHOSPHAMIDE; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; TRASTUZUMAB; TROPONIN I;

ADJUVANT THERAPY; ADULT; AGED; ALOPECIA; ANEMIA; ANOREXIA; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER PATIENT; CARDIOTOXICITY; CLINICAL ARTICLE; CONSTIPATION; DIARRHEA; DOPPLER ECHOCARDIOGRAPHY; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ELDERLY CARE; FATIGUE; FEASIBILITY STUDY; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; GERIATRIC PATIENT; HAND FOOT SYNDROME; HEART ARRHYTHMIA; HEART FAILURE; HEART FUNCTION TEST; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE INJURY; HUMAN; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; PILOT STUDY; PROPHYLAXIS; RASH; REVIEW; STOMATITIS; TREATMENT PLANNING; VOMITING;

EID: 46149120626     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2008.01.001     Document Type: Review

References (20)

1. Swain S.M., Whaley F.S., and Ewer M.S. Congestive heart failure in patients treated with doxorubicin-a retrospective analysis of three trials. Cancer 97 (2003) 2869-2879
2. O'Brien M.E., Wigler N., Inbar M., et al. Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer. Ann Oncol 15 (2004) 440-449
3. Wildiers H., and Brain E.G.C. Adjuvant chemotherapy in elderly patients with breast cancer: where are we?. Curr Opin Oncol 17 6 (2005) 566-572
4. Silverman P., Overmoyer B., Holder L., Tripathy D., Marrs N., and Sharpington T. Doxil and intravenous cyclophophamide as first-line therapy for patients with metastastic breast cancer (MBC): interim results of an ongoing pilot trial. Proc Am Soc Clin Oncol (1999) [abstract]
5. Srimuninnimit V., Sinlaratana P., Bhothisuwan K., and Pattaranutaporn P. Phase II study with the combination of pegylated liposomal doxorubicin (Caelyx) and cyclophophamide (CC) in locally advanced breast cancer (LABC). Proc Am Soc Clin Oncol (2002) [abstract]
6. Leighl N.B., Burkes R.L., Dancey J.E., et al. A phase I study of pegylated liposomal doxorubicin hydrochloride (Caelyx) in combination with cyclophosphamide and vincristine as second-line treatment of patients with small-cell lung cancer. Clin Lung Cancer 5 (2003) 107-112
7. Rose P.G. Pegylated liposomal doxorubicin: optimizing the dosing schedule in ovarian cancer. Oncologist 10 (2005) 205-214
8. Lichtman S.M., Wildiers H., Chatelut E., et al. International Society of Geriatric Oncology chemotherapy taskforce: evaluation of chemotherapy in older patients-an analysis of the medical literature. J Clin Oncol 25 (2007) 1832-1843
9. Shan K., Lincoff A.M., and Young J.B. Anthracycline-induced cardiotoxicity. Ann Intern Med 125 (1996) 47-58
10. Urheim S., Edvardsen T., Torp H., Angelsen B., and Smiseth O.A. Myocardial strain by Doppler echocardiography. Validation of a new method to quantify regional myocardial function. Circulation 102 (2000) 1158-1164
11. Voigt J.U., Exner B., Schmiedehausen K., et al. Strain-rate imaging during dobutamine stress echocardiography provides objective evidence of inducible ischemia. Circulation 107 (2003) 2120-2126
12. Heimdal A., Stoylen A., Torp H., and Skjaerpe T. Real-time strain rate imaging of the left ventricle by ultrasound. J Am Soc Echocardiogr 11 (1998) 1013-1019
13. Kowalski M., Kukulski T., Jamal F., et al. Can natural strain and strain rate quantify regional myocardial deformation? A study in healthy subjects. Ultrasound Med Biol 27 (2001) 1087-1097
14. Buyse G., Mertens L., Di S.G., et al. Idebenone treatment in Friedreich's ataxia: neurological, cardiac, and biochemical monitoring. Neurology 60 (2003) 1679-1681
15. Neilan T.G., Jassal D.S., Perez-Sanz T.M., et al. Tissue Doppler imaging predicts left ventricular dysfunction and mortality in a murine model of cardiac injury. Eur Heart J 27 (2006) 1868-1875
16. Ganame J., Claus P., Eyskens B., et al. Acute cardiac functional and morphological changes after anthracycline infusions in children. Am J Cardiol 99 (2007) 974-977
17. de Lemos J.A., McGuire D.K., and Drazner M.H. B-type natriuretic peptide in cardiovascular disease. Lancet 362 (2003) 316-322
18. Okumura H., Iuchi K., Yoshida T., et al. Brain natriuretic peptide is a predictor of anthracycline-induced cardiotoxicity. Acta Haematol 104 (2000) 158-163
19. Lipshultz S.E., Rifai N., Sallan S.E., et al. Predictive value of cardiac troponin T in pediatric patients at risk for myocardial injury. Circulation 96 (1997) 2641-2648
20. Cardinale D., Sandri M.T., Colombo A., et al. Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy. Circulation 109 (2004) 2749-2754